Dermatologic ultrasound in the management of childhood linear morphea

Laverde-Saad, Alexandra; López-Negrete, Elena; Roustán, Gastón; Alfageme, Fernando

doi:10.5070/d327754364

Cited by 6 publications

(5 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…On ultrasound, the appearance varies according to the phase of activity of morphea. 37,38,[127][128][129][130][131][132][133][134] Thus, in the inflammatory phase, there is thickening and decreased echogenicity of the dermis, loss of the dermal-hypodermal border, increased echogenicity of the hypodermis, and hypervascularity of the dermis or hypodermis with slow flow vessels. In the inactive atrophic phase, there is thinning of the dermis and hypodermis with loss of the hypodermal fat and hypovascularity (Figure 15).…”

Section: Advances In Inflammatory Diseasesmentioning

confidence: 99%

See 1 more Smart Citation

Top Advances in Dermatologic Ultrasound

Wortsman

2022

J of Ultrasound Medicine

View full text Add to dashboard Cite

The advances in dermatologic ultrasound have been significantly influenced by the development of high‐ and ultrahigh‐frequency probes, the provision of guidelines for performing the examinations, and a growing number of publications in the field. This review analyzes the most significant contributions that have impacted the daily practice of dermatologists in recent years. This includes the advances in anatomical detection and the patterns of benign and malignant cutaneous tumors, inflammatory dermatologic conditions, vascular anomalies, nail abnormalities, and aesthetic procedures. The knowledge of these advances is a primer for the operators of these examinations.

show abstract

Section: Advances In Inflammatory Diseasesmentioning

confidence: 99%

“…This is an autoimmune disease that corresponds to the cutaneous manifestation of scleroderma. On ultrasound, the appearance varies according to the phase of activity of morphea 37,38,127–134 …”

Section: Advances In Inflammatory Diseasesmentioning

confidence: 99%

Top Advances in Dermatologic Ultrasound

Wortsman

2022

J of Ultrasound Medicine

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

“…One of the most challenging issues in treating morphea patients is the lack of globally accepted assessment tools for monitoring the results of treatment and disease activity. [33][34][35][36] In this regard, ultrasound is a potential and reliable imaging modality in the quantitative morphea assessment. However, ultrasound has limitations such as being operator dependent and lack of consistent intra or interoperator measurement of tissue thickness.…”

Section: Discussionmentioning

confidence: 99%

Role of imaging in morphea assessment: A review of the literature

Khorasanizadeh

Kalantari

Etesami

2023

Skin Research and Technology

View full text Add to dashboard Cite

Background: Localized scleroderma, known as morphea, is a connective tissue disorder characterized by inflammation and fibrosis of the skin and the soft tissue. There exist no universally accepted validated outcome measures in order to monitor the disease activity. Besides clinical scores to evaluate outcome measures, imaging modalities are increasingly utilized in assessing patients with morphea, such as high-frequency ultrasonography (US), shear-wave elastography (SWE), and magnetic resonance imaging (MRI). However, the accuracy of these imaging modalities in monitoring morphea activity is not yet clear. Aims:To review the literature regarding the role of imaging modalities in assessing patients with morphea. Materials & Methods:In this study, we searched the PubMed/Medline database for articles published from inception until February 2023.Results: A total number of 23 original articles in three categories of US, elastography, and MRI were included.Discussion: Regarding US, criteria, including increased dermal thickness, increased echogenicity of the subcutaneous tissue, and decreased dermal echogenicity, were indicators of active morphea lesions when using high frequencies probe (18)(19)(20) color Doppler sonography. Moreover, studies evaluating SWE, a novel method to quantitatively assess tissue stiffness, demonstrated increased dermal stiffness in active lesions. Conclusion:Studies showed that MRI can help to determine the depth of disease, particularly as a first-line and follow-up diagnostic tool, especially in generalized and deep morphea. In addition, brain MRI may be useful for patients with localized craniofacial scleroderma experiencing new or worsening neurological symptoms.

show abstract

“…6 This scoring was based on the color Doppler examination of the corporal regions involved in morphea and their ultrasonographic signs of activity already published in the literature. 3,[7][8][9] These activity signs include the increased subcutaneous echogenicity and/or loss of definition of the dermal-hypodermal border and the increase of the dermal and/or hypodermal vascularity. 3,6,8 However, this scoring was simplified and only considered macro corporal regions due to extensive data analysis in this study.…”

mentioning

confidence: 99%

Ultrasound Morphea Activity Scoring (US‐MAS): Modified US‐MAS

Wortsman

Vera‐Kellet

2023

J of Ultrasound Medicine

View full text Add to dashboard Cite

Morphea, an autoimmune connective tissue disease that affects the skin, can be supported by color Doppler ultrasound in its diagnosis and assessment of activity. To date, there are no reliable laboratory parameters to track activity, and ultrasound presents a higher axial spatial resolution than magnetic resonance imaging and computed tomography, which is critical for studying the superficial layers. The quality of the ultrasonographic assessment of activity in morphea depends on the standardization and features of the acquisition of the anatomical data. We propose a detailed ultrasound morphea activity scoring called modified US‐MAS (mUS‐MAS) that could allow us to systematically register the cutaneous abnormalities in the corporal regions and their subregions. The selection of the scanning sites will depend on the corporal regions of involvement and their adjacent segments. Through systematic and sequential ultrasound data analysis, we propose that this scoring system can better support description and activity tracking accuracy.

show abstract

Dermatologic ultrasound in the management of childhood linear morphea

Cited by 6 publications

References 0 publications

Top Advances in Dermatologic Ultrasound

Top Advances in Dermatologic Ultrasound

Role of imaging in morphea assessment: A review of the literature

Ultrasound Morphea Activity Scoring (US‐MAS): Modified US‐MAS

Contact Info

Product

Resources

About